Enzyme-linked immunosorbent choriomammotropin assay

Area of Science:

• Biochemistry
• Immunology
• Clinical Chemistry

Background:

• Choriomammotropin, also known as human placental lactogen, is a key hormone in pregnancy.
• Accurate measurement of choriomammotropin is important for monitoring pregnancy health.
• Existing methods for choriomammotropin determination may be time-consuming or less precise.

Purpose of the Study:

• To develop and validate a rapid and precise enzyme-linked immunosorbent assay (ELISA) for quantifying choriomammotropin in human serum.
• To assess the assay's performance characteristics, including precision and correlation with a standard method.

Main Methods:

• Development of an enzyme-linked immunosorbent assay utilizing unlabeled hormone competition with a choriomammotropin-beta-galactosidase conjugate.
• Antibody immobilization on polystyrene tubes for the assay.
• Assay validation using intra-day and inter-day coefficient of variation (CV) calculations.
• Comparison of assay results with radial immunodiffusion (RID) using clinical samples.

Main Results:

• The developed ELISA can be completed within 2.5 hours.
• High precision was observed, with an intra-day CV of 5.7% and an inter-day CV of 7.9%.
• A strong correlation (r = 0.91) was found between the ELISA results and radial immunodiffusion for 48 clinical samples, with the regression equation y = 1.05x + 0.78.

Conclusions:

• The developed ELISA provides a rapid, precise, and reliable method for determining serum choriomammotropin levels.
• This assay offers a valuable alternative to existing methods for clinical use.
• The assay's performance suggests its utility in routine diagnostic and research settings for pregnancy monitoring.